All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Immunogenicity and safety of pandemic H1N1 2009 influenza vaccine for HIV-1 patients

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43907065" target="_blank" >RIV/00216208:11120/12:43907065 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.4149/av_2012_04_349" target="_blank" >http://dx.doi.org/10.4149/av_2012_04_349</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.4149/av_2012_04_349" target="_blank" >10.4149/av_2012_04_349</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Immunogenicity and safety of pandemic H1N1 2009 influenza vaccine for HIV-1 patients

  • Original language description

    The advent of the 2009 H1N1 pandemic influenza has raised concerns about the immunogenicity and safety of vaccines against the new virus, especially in immunocompromised individuals. In our study we evaluated the immunogenicity and safety of pandemic influenza vaccine in 34 HIV-1 infected patients. For immunization was we used a single dose of adjuvanted inactivated split-virion pandemic H1N1 influenza vaccine containing 3.75 ug of hemagglutinin (A/California/7/2009) and adjuvant AS03. Two serum sampleswere collected from each patient - first on day 0, just before vaccination and the other on day 28, after vaccination. Antibody production was tested by hemagglutinin inhibition assay according to the World Health Organization methodology. The mean baseline CD4+ T lymphocyte count was 511/ul (range 90-1151). After vaccination, protective titers >1:40 were found in 24 (70.5%) vaccines, and at least a fourfold increase in antibody titers was detected in 27 vaccines (79.4%). Seroconversion

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FN - Epidemiology, infection diseases and clinical immunology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Acta Virologica

  • ISSN

    0001-723X

  • e-ISSN

  • Volume of the periodical

    56

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    SK - SLOVAKIA

  • Number of pages

    3

  • Pages from-to

    349-351

  • UT code for WoS article

    000313403400011

  • EID of the result in the Scopus database